Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Endocrinology and Metabolism Clinics of North America|October 30, 2017
The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney DiseaseLadan Zand, Rajiv KumarSeminars in Dialysis|December 18, 2015
Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical TrialsLadan Zand, Rajiv KumarClinical Kidney Journal|September 5, 2023
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathyLadan Zand, Fernando C FervenzaMayo Clinic Proceedings|April 9, 2026
How to Manage an Adult Patient With IgA Nephropathy in the Current Era?Ladan Zand, Fernando C FervenzaClinical Kidney Journal|June 9, 2016
Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysisWonngarm Kittanamongkolchai, Wisit Cheungpasitporn, Ladan ZandAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 19, 2025
What's New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A ReviewLadan Zand, Fernando C Fervenza, Sanjeev SethiClinical Nephrology|December 21, 2012
Role of kidney Doppler ultrasonography in the diagnosis and management of anuric kidney failureLadan Zand, Bernard F King, Qi QianKidney360|April 4, 2022
Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9)Nattawat Klomjit, Mariam Priya Alexander, Ladan ZandThe American Journal of Medicine|April 6, 2010
Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidityLadan Zand, Kevin P McKian, Qi QianAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 21, 2020
Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 CasesNattawat Klomjit, Fernando C Fervenza, Ladan ZandPageof 10